Welcome to our dedicated page for Quantinuum SEC filings (Ticker: QNT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Quantinuum's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Quantinuum's regulatory disclosures and financial reporting.
Quantinuum Inc. director Prineha Narang reported new equity activity in Class A Common Stock. On June 5, 2026, Narang made an open-market purchase of 200 shares at $60.00 per share, bringing direct holdings to 6,033 shares.
On June 4, 2026, Narang also received an award of 5,833 restricted stock units, each representing one share of Class A Common Stock. According to the award terms, these RSUs will vest in three equal annual installments beginning on June 5, 2027, adding a long-term equity component to the director’s compensation.
Quantinuum Inc. director Joseph Jimenez reported new share acquisitions. He made an open-market purchase of 66,665 shares of Class A Common Stock at $60.00 per share on June 5, 2026, bringing his directly held stake to 72,498 shares.
On June 4, 2026, he also received a grant of 5,833 restricted stock units, each representing one future share of Class A Common Stock. These RSUs vest in three equal annual installments beginning on June 5, 2027, aligning part of his compensation with the company’s long-term performance.
Quantinuum Inc.’s Chief Financial Officer Nitesh Sharan reported several acquisitions of Class A Common Stock. He received 289,798 restricted shares in a recapitalization transaction and a further 44,548 restricted shares as a stock award. These awards were made at no cash cost to him.
After these awards, he made an open-market purchase of 6,500 shares at $60.00 per share. Following these transactions, he directly owns 340,846 Class A Common Stock shares. One award was completed before Quantinuum’s initial public offering and is being reported under Rule 16a-2(a).
Quantinuum Inc. director Hal Barron significantly increased his direct stake through a large open-market purchase and a new equity award. On Class A Common Stock, he bought 250,000 shares in the open market at $60.00 per share, bringing his direct holdings to 255,833 shares after the trade.
He also received an award of 5,833 restricted stock units, each representing one future share of Class A Common Stock. These RSUs will vest in three equal annual installments beginning on June 5, 2027, adding a long-term, performance-aligned component to his ownership.
Quantinuum Inc. director Eric Branderiz increased his stake through a mix of grant and open-market buying. He received 5,833 shares of Class A Common Stock as a restricted stock unit (RSU) award on June 4, 2026, at a stated price of $0.00 per share. These RSUs vest in three equal annual installments beginning on June 5, 2027, each convertible into one share of Class A Common Stock.
On June 5, 2026, he made an open-market purchase of 8,334 shares at $60.00 per share. Following the purchase, his direct holdings reported in this filing rose to 14,167 shares of Class A Common Stock.
Quantinuum Inc. director Vimal Kapur reported an open-market purchase of 13,000 shares of Class A Common Stock. The transaction took place on 2026-06-05 at a price of $60.0000 per share. Following this purchase, Kapur directly holds 13,000 shares of Quantinuum common stock.
Quantinuum Inc. director Michal Stepniak reported an open-market purchase of Class A Common Stock. On June 5, he bought 13,333 shares at a price of $60.00 per share and now holds 13,333 shares directly following this transaction.
Quantinuum Inc. Chief Strategy Officer Kevin Scott Dehoff increased his direct stake in Class A Common Stock through both a grant and a market purchase. On June 3, 2026, he acquired 111,460 restricted shares in connection with a recapitalization transaction at a stated price of $0.00 per share. On June 5, 2026, he made an open-market purchase of an additional 15,000 shares at $60.00 per share. Following these transactions, Dehoff directly owns 126,460 Class A shares, aligning his interests more closely with shareholders ahead of the company’s initial public offering.
Quantinuum Inc. director Paul R. Daugherty reported two equity transactions in Class A Common Stock. He purchased 4,000 shares in an open-market transaction at $60.00 per share on June 5, 2026, bringing his directly held common shares to 9,833.
He also received a grant of 5,833 restricted stock units, each representing a contingent right to one share of Class A Common Stock. These RSUs vest in three equal annual installments beginning on June 5, 2027, adding a long-term, time-based equity component to his compensation.
Quantinuum Inc. director Kenneth D. Denman increased his stake through both a purchase and an equity award. He bought 14,000 shares of Class A Common Stock in an open-market transaction at $60.00 per share on June 5, 2026, bringing his directly held shares to 19,833.
On June 4, 2026, he also received a grant of 5,833 restricted stock units (RSUs), each representing one future share of Class A Common Stock. These RSUs vest in three equal annual installments beginning on June 5, 2027, adding a long-term, stock-based component to his compensation.